MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 207 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $233,310 | +16.6% | 1,010 | +22.3% | 0.00% | – |
| Q1 2023 | $200,107 | -21.9% | 826 | -6.5% | 0.00% | – |
| Q4 2022 | $256,291 | -30.7% | 883 | -76.6% | 0.00% | – |
| Q1 2022 | $370,000 | +65.2% | 3,768 | +33.9% | 0.00% | – |
| Q3 2021 | $224,000 | -23.8% | 2,813 | -6.8% | 0.00% | – |
| Q2 2021 | $294,000 | +7.3% | 3,018 | +28.8% | 0.00% | – |
| Q1 2021 | $274,000 | +7.5% | 2,343 | +3.7% | 0.00% | -100.0% |
| Q4 2018 | $255,000 | -9.3% | 2,260 | +72.1% | 0.00% | 0.0% |
| Q3 2018 | $281,000 | -24.1% | 1,313 | -0.8% | 0.00% | 0.0% |
| Q2 2018 | $370,000 | – | 1,323 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
| L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
| Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
| Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
| ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
| Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
| Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
| Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |